Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
94
AFBI Quote, Financials, Valuation and Earnings
Last price:
$20.47
Seasonality move
:
-5.15%
Day range:
$20.50 - $20.60
52-week range:
$17.00 - $22.50
Dividend yield:
0%
P/E ratio:
15.80x
P/S ratio:
2.49x
P/B ratio:
0.98x
Volume:
1.9K
Avg. volume:
3.9K
1-year change:
12.64%
Market cap:
$125M
Revenue:
$52.9M
EPS (TTM):
$1.30
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $35.2M | $34.5M | $45.2M | $50M | $52.9M | |
| Revenue Growth (YoY) | 8.5% | -2% | 30.78% | 10.68% | 5.89% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -$385K | -- | |
| Operating Expenses | -$9.9M | -$9.3M | -$8.4M | -$7M | -$11.2M | |
| Operating Income | $9.9M | $9.3M | $8.4M | $7M | $11.2M | |
| Net Interest Expenses | $497K | -- | $1.4M | $2.4M | $2.1M | |
| EBT. Incl. Unusual Items | $9.9M | $9.3M | $8.4M | $7M | $11.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $2.2M | $1.9M | $1.5M | $2.9M | |
| Net Income to Company | $7.6M | $7.1M | $6.4M | $5.4M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.6M | $7.1M | $6.4M | $5.4M | $8.3M | |
| Basic EPS (Cont. Ops) | $1.10 | $1.07 | $1.00 | $0.85 | $1.33 | |
| Diluted EPS (Cont. Ops) | $1.10 | $1.06 | $0.98 | $0.83 | $1.29 | |
| Weighted Average Basic Share | $6.9M | $6.7M | $6.5M | $6.4M | $6.3M | |
| Weighted Average Diluted Share | $6.9M | $6.8M | $6.6M | $6.6M | $6.4M | |
| EBITDA | -- | $12M | $24.6M | $26.5M | -- | |
| EBIT | $13.1M | $11.7M | $23.9M | $25.8M | $31.1M | |
| Revenue (Reported) | $35.2M | $34.5M | $45.2M | $50M | $52.9M | |
| Operating Income (Reported) | $9.9M | $9.3M | $8.4M | $7M | $11.2M | |
| Operating Income (Adjusted) | $13.1M | $11.7M | $23.9M | $25.8M | $31.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.9M | $9.5M | $11.7M | $12.4M | $13.5M | |
| Revenue Growth (YoY) | -6.13% | 20.22% | 22.48% | 5.98% | 8.78% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -$385K | -- | |
| Operating Expenses | -$1.8M | -$2.2M | -$1.9M | -$1.6M | -$3.1M | |
| Operating Income | $1.8M | $2.2M | $1.9M | $1.6M | $3.1M | |
| Net Interest Expenses | $132K | $20K | $300K | $625K | $525K | |
| EBT. Incl. Unusual Items | $1.8M | $2.2M | $1.9M | $1.6M | $3.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $442K | $513K | $414K | $256K | $945K | |
| Net Income to Company | $1.3M | $1.7M | $1.5M | $1.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.3M | $1.7M | $1.5M | $1.3M | $2.1M | |
| Basic EPS (Cont. Ops) | $0.19 | $0.26 | $0.24 | $0.21 | $0.35 | |
| Diluted EPS (Cont. Ops) | $0.19 | $0.25 | $0.23 | $0.20 | $0.34 | |
| Weighted Average Basic Share | $6.9M | $6.6M | $6.4M | $6.4M | $6.1M | |
| Weighted Average Diluted Share | $6.9M | $6.7M | $6.5M | $6.6M | $6.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.5M | $3.9M | $6.3M | $6.4M | $8M | |
| Revenue (Reported) | $7.9M | $9.5M | $11.7M | $12.4M | $13.5M | |
| Operating Income (Reported) | $1.8M | $2.2M | $1.9M | $1.6M | $3.1M | |
| Operating Income (Adjusted) | $2.5M | $3.9M | $6.3M | $6.4M | $8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $35.2M | $34.5M | $45.2M | $50M | $52.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -$385K | -- | |
| Operating Expenses | -$10.8M | -$9.3M | -$8.4M | -$7M | -$11.2M | |
| Operating Income | $10.8M | $9.3M | $8.4M | $7M | $11.2M | |
| Net Interest Expenses | $496K | -- | $1.4M | $2.4M | $2.1M | |
| EBT. Incl. Unusual Items | $9.9M | $9.3M | $8.4M | $7M | $11.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $2.2M | $1.9M | $1.5M | $2.9M | |
| Net Income to Company | $7.6M | $7.1M | $6.4M | $5.4M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.6M | $7.1M | $6.4M | $5.4M | $8.3M | |
| Basic EPS (Cont. Ops) | $1.10 | $1.07 | $1.00 | $0.85 | $1.33 | |
| Diluted EPS (Cont. Ops) | $1.10 | $1.05 | $0.98 | $0.83 | $1.30 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $13.1M | $11.7M | $23.9M | $25.8M | $31.1M | |
| Revenue (Reported) | $35.2M | $34.5M | $45.2M | $50M | $52.9M | |
| Operating Income (Reported) | $10.8M | $9.3M | $8.4M | $7M | $11.2M | |
| Operating Income (Adjusted) | $13.1M | $11.7M | $23.9M | $25.8M | $31.1M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $34.5M | $45.2M | $50M | $52.9M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -$385K | -- | -- | |
| Operating Expenses | -$9.3M | -$8.4M | -$7M | -$11.2M | -- | |
| Operating Income | $9.3M | $8.4M | $7M | $11.2M | -- | |
| Net Interest Expenses | $121K | $1.4M | $2.4M | $2.1M | -- | |
| EBT. Incl. Unusual Items | $9.3M | $8.4M | $7M | $11.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $1.9M | $1.5M | $2.9M | -- | |
| Net Income to Company | $7.1M | $6.4M | $5.4M | $1.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.1M | $6.4M | $5.4M | $8.3M | -- | |
| Basic EPS (Cont. Ops) | $1.07 | $1.00 | $0.85 | $1.33 | -- | |
| Diluted EPS (Cont. Ops) | $1.05 | $0.98 | $0.83 | $1.30 | -- | |
| Weighted Average Basic Share | $26.7M | $25.9M | $25.7M | $25.1M | -- | |
| Weighted Average Diluted Share | $27.1M | $26.2M | $26.3M | $25.8M | -- | |
| EBITDA | $1.1M | $5.3M | $6.4M | $7.4M | -- | |
| EBIT | $11.7M | $23.9M | $25.8M | $31.1M | -- | |
| Revenue (Reported) | $34.5M | $45.2M | $50M | $52.9M | -- | |
| Operating Income (Reported) | $9.3M | $8.4M | $7M | $11.2M | -- | |
| Operating Income (Adjusted) | $11.7M | $23.9M | $25.8M | $31.1M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.2M | $2.9M | $6M | $7.1M | $6.9M | |
| Short Term Investments | $48.6M | $46.2M | $48.6M | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $115.3M | $29.2M | $52.9M | $43.7M | $53.9M | |
| Property Plant And Equipment | $3.8M | $4.3M | $3.8M | $4.5M | $2.8M | |
| Long-Term Investments | $98M | $24.5M | $49.4M | $40.5M | $53.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $18.6M | $18.4M | $18.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $788.1M | $791.3M | $843.3M | $866.8M | $881.7M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $193.9M | $190.3M | $154.7M | $424.7M | $372.8M | |
| Long-Term Debt | $49M | $10M | $40M | $59.8M | $54M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $667.1M | $674.2M | $721.7M | $737.7M | $754.7M | |
| Common Stock | $69K | $66K | $64K | $64K | $61K | |
| Other Common Equity Adj | -$358K | -$6.7M | -$6.3M | -$5.7M | -- | |
| Common Equity | $121M | $117.1M | $121.5M | $129.1M | $127M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $121M | $117.1M | $121.5M | $129.1M | $127M | |
| Total Liabilities and Equity | $788.1M | $791.3M | $843.3M | $866.8M | $881.7M | |
| Cash and Short Terms | $160.3M | $72.5M | $98.6M | $41.4M | -- | |
| Total Debt | $49M | $10M | $40M | $59.8M | $54M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.2M | $2.9M | $6M | $7.1M | $6.9M | |
| Short Term Investments | $48.6M | $46.2M | $48.6M | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $115.3M | $29.2M | $52.9M | $43.7M | $53.9M | |
| Property Plant And Equipment | $3.8M | $4.3M | $3.8M | $4.5M | $2.8M | |
| Long-Term Investments | $98M | $24.5M | $49.4M | $40.5M | $53.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $18.6M | $18.4M | $18.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $788.1M | $791.3M | $843.3M | $866.8M | $881.7M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $193.9M | $190.3M | $154.7M | $424.7M | $372.8M | |
| Long-Term Debt | $49M | $10M | $40M | $59.8M | $54M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $667.1M | $674.2M | $721.7M | $737.7M | $754.7M | |
| Common Stock | $69K | $66K | $64K | $64K | $61K | |
| Other Common Equity Adj | -$358K | -$6.7M | -$6.3M | -$5.7M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $121M | $117.1M | $121.5M | $129.1M | $127M | |
| Total Liabilities and Equity | $788.1M | $791.3M | $843.3M | $866.8M | $881.7M | |
| Cash and Short Terms | $160.3M | $72.5M | $98.6M | $41.4M | -- | |
| Total Debt | $49M | $10M | $40M | $59.8M | $54M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.1M | $7.6M | $7.1M | $6.4M | $5.4M | |
| Depreciation & Amoritzation | $697K | $674K | $338K | $734K | $738K | |
| Stock-Based Compensation | $298K | $679K | $1M | $1.4M | $1.5M | |
| Change in Accounts Receivable | -$4.3M | $2.8M | -$716K | -$527K | $731K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.4M | $11.9M | $7.6M | $7.9M | $6.8M | |
| Capital Expenditures | $451K | $830K | $1.4M | $527K | $422K | |
| Cash Acquisitions | -$22.7M | -- | -- | -- | -- | |
| Cash From Investing | -$110.4M | -$9.6M | -$93.7M | -$28.1M | -$33.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $150.8M | $35M | $105M | $85M | $35.9M | |
| Long-Term Debt Repaid | -$60M | -$110.8M | -$143M | -$55.1M | -$17.1M | |
| Repurchase of Common Stock | -- | -- | -- | $3.3M | -- | |
| Other Financing Activities | -- | -$4.7M | -- | -- | -- | |
| Cash From Financing | $239.1M | -$68.7M | $701K | $44M | $17.9M | |
| Beginning Cash (CF) | $48.1M | $178.3M | $111.8M | $26.3M | $50M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $130.1M | -$66.5M | -$85.5M | $23.7M | -$8.6M | |
| Ending Cash (CF) | $178.3M | $111.8M | $26.3M | $50M | $41.4M | |
| Levered Free Cash Flow | $920K | $11M | $6.2M | $7.3M | $6.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3M | $1.7M | $1.5M | $1.3M | -- | |
| Depreciation & Amoritzation | $147K | -- | -- | -- | -- | |
| Stock-Based Compensation | $191K | $310K | $384K | $358K | -- | |
| Change in Accounts Receivable | -$362K | -$884K | $4K | $702K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.3M | -$646K | $1.8M | $865K | -- | |
| Capital Expenditures | $253K | $464K | $175K | $23K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$17.4M | -$26.3M | $1.6M | -$1.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $25K | $20M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $284K | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$427K | $12.8M | -$14.9M | -$10.3M | -- | |
| Beginning Cash (CF) | $130.9M | $40.5M | $61.5M | $52.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$19.1M | -$14.2M | -$11.5M | -$10.9M | -- | |
| Ending Cash (CF) | $111.8M | $26.3M | $50M | $41.4M | -- | |
| Levered Free Cash Flow | -$1.6M | -$1.1M | $1.6M | $842K | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.6M | $7.1M | $6.4M | $5.4M | -- | |
| Depreciation & Amoritzation | $674K | $338K | $735K | $738K | -- | |
| Stock-Based Compensation | $679K | $1M | $1.4M | $1.5M | -- | |
| Change in Accounts Receivable | $2.8M | -$716K | -$527K | $731K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.9M | $7.6M | $7.9M | $6.8M | -- | |
| Capital Expenditures | $830K | $1.4M | $527K | $422K | $329K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$9.6M | -$93.7M | -$28.1M | -$33.2M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $35M | $105M | $85M | $35.9M | -- | |
| Long-Term Debt Repaid | -$110.8M | -$143M | -$55.1M | -$17.1M | -- | |
| Repurchase of Common Stock | -- | -- | $3.3M | -- | -- | |
| Other Financing Activities | -$4.7M | -- | -- | -- | -- | |
| Cash From Financing | -$68.7M | $701K | $44M | $17.9M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$66.5M | -$85.5M | $23.7M | -$8.6M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $11M | $6.2M | $7.3M | $6.4M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.1M | $6.4M | $5.4M | $1.8M | -- | |
| Depreciation & Amoritzation | -$804K | $183K | $162K | $193K | -- | |
| Stock-Based Compensation | $1M | $1.4M | $1.5M | $1.7M | -- | |
| Change in Accounts Receivable | -$716K | -$527K | $731K | -$1.2M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.6M | $7.9M | $6.8M | $9.4M | -- | |
| Capital Expenditures | $1.4M | $527K | $422K | $329K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$93.7M | -$28.1M | -$33.2M | -$14.2M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $8.8M | -- | |
| Special Dividend Paid | -- | -- | -- | $1.5M | -- | |
| Long-Term Debt Issued | $105M | $85M | $35.9M | -- | -- | |
| Long-Term Debt Repaid | -$143M | -$55.1M | -$17.1M | -$4.8M | -- | |
| Repurchase of Common Stock | -- | $3.3M | -- | $4.1M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $701K | $44M | $17.9M | $48.2M | -- | |
| Beginning Cash (CF) | $277.6M | $307.6M | $214.1M | $41.4M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$85.5M | $23.7M | -$8.6M | $43.4M | -- | |
| Ending Cash (CF) | $192.1M | $331.3M | $205.5M | $74.7M | -- | |
| Levered Free Cash Flow | $6.2M | $7.3M | $6.4M | $9.1M | -- | |
Get AFBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AFBI
Sector
P/E ratio
15.80x
12.54x
PEG ratio
0.28x
0.32x
P/B ratio
0.98x
1.15x
Price / LTM sales
2.49x
1.86x
Growth Metrics
AFBI
Sector
Revenue growth
8.78%
5.54%
Earnings growth
67.32%
11.36%
Revenue (5-year growth)
10.26%
8.68%
Earnings forecast
--
$0.64
Profitability
AFBI
Sector
Profitability FY 2025
--
--
Return on invested capital
4.61%
5.2%
Return on assets
0.92%
1.03%
Return on equity
6.64%
9.91%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
AFBI
Sector
Total cash
$130.4M
$407.2M
Short term investments
--
$192.4M
Total assets
$881.7M
$3.1B
Long term debt
$54M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
